Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

Detaylı Bibliyografya
Asıl Yazarlar:	Onakpoya, I, Heneghan, C, Aronson, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BioMed Central 2016

Benzer Materyaller

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
Yazar:: Onakpoya, I, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
Yazar:: Onakpoya, IJ, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
Yazar:: Onakpoya, I, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
Yazar:: Onakpoya, I
Baskı/Yayın Bilgisi: (2017)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
Yazar:: Onakpoya, I, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
Yazar:: Onakpoya, I, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Pharmacogenetics and adverse drug reactions
Yazar:: Ferner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

An agenda for research on adverse drug reactions.
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2007)

Adverse drug reactions--no farewell to harms.
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2007)

Adverse drug reactions: definitions, diagnosis, and management.
Yazar:: Edwards, I, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2008)

Adverse drug reactions: keeping up to date.
Yazar:: Aronson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
Yazar:: Loke, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2013)

Paradoxical reactions: Under-recognized adverse effects of drugs?
Yazar:: Hauben, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

National differences in publishing papers on adverse drug reactions.
Yazar:: Ferner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
Yazar:: Talbot, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
Yazar:: Talbot, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2012)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
Yazar:: Smith, C, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2017)

Health risks of unknown medicines: evidence from adverse drug reactions in Laos
Yazar:: Caillet, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Joining the DoTS: new approach to classifying adverse drug reactions.
Yazar:: Aronson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
Yazar:: Onakpoya, IJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (2005)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
Yazar:: McDowell, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Pharmacovigilance and reporting adverse drug reactions.
Yazar:: Isa NM,
Baskı/Yayın Bilgisi: (2014)

Monitoring for the Adverse Effects of Drugs
Yazar:: Coleman, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
Yazar:: Aronson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
Yazar:: Onakpoya, I, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
Yazar:: Derry, S, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
Yazar:: Derry, S, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Patient Reporting of Adverse Drug Reactions (ADRs)
Yazar:: Hariraj, Vidhya, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Clinical pharmacology. Adverse drug interactions.
Yazar:: Aronson, J, ve diğerleri
Baskı/Yayın Bilgisi: (1981)

Adverse drug reactions (ADRs) in geriatric hospitalized patients=Adverse drug reaction (ADRs) pada pasien rawat inap geriatri
Yazar:: Perpustakaan UGM, i-lib
Baskı/Yayın Bilgisi: (2008)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A Pharmacoinformatic Prediction Model For Adverse Drug Reactions
Yazar:: Omar, Moayyad Jamal Abdel Jabbar Al
Baskı/Yayın Bilgisi: (2010)

Drug-related postural hypotension: to withdraw or not to withdraw (a case series)
Yazar:: Mohamad, Fadzilah, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Lorcaserin in obesity: minimal benefits and ill-defined harms
Yazar:: Onakpoya, I, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Gold standards in pharmacovigilance: the use of definitive anecdotal adverse drug reactions as pure gold and high grade ore
Yazar:: Hauben, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)